Does CILTACABTAGENE AUTOLEUCEL Cause Transfusion? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Transfusion have been filed in association with CILTACABTAGENE AUTOLEUCEL (CARVYKTI). This represents 0.6% of all adverse event reports for CILTACABTAGENE AUTOLEUCEL.
22
Reports of Transfusion with CILTACABTAGENE AUTOLEUCEL
0.6%
of all CILTACABTAGENE AUTOLEUCEL reports
1
Deaths
7
Hospitalizations
How Dangerous Is Transfusion From CILTACABTAGENE AUTOLEUCEL?
Of the 22 reports, 1 (4.5%) resulted in death, 7 (31.8%) required hospitalization, and 1 (4.5%) were considered life-threatening.
Is Transfusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CILTACABTAGENE AUTOLEUCEL. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does CILTACABTAGENE AUTOLEUCEL Cause?
Cytokine release syndrome (570)
Pyrexia (242)
Immune effector cell-associated neurotoxicity syndrome (232)
Parkinsonism (209)
Hospitalisation (193)
Adverse event (143)
Neurotoxicity (140)
Death (130)
Malaise (126)
Fatigue (123)
What Other Drugs Cause Transfusion?
MACITENTAN (858)
VENETOCLAX (793)
APIXABAN (561)
ECULIZUMAB (454)
WARFARIN (377)
SELEXIPAG (289)
ADALIMUMAB (264)
AMBRISENTAN (244)
CEDAZURIDINE\DECITABINE (229)
EPOPROSTENOL (225)
Which CILTACABTAGENE AUTOLEUCEL Alternatives Have Lower Transfusion Risk?
CILTACABTAGENE AUTOLEUCEL vs CIMETIDINE
CILTACABTAGENE AUTOLEUCEL vs CIMZIA
CILTACABTAGENE AUTOLEUCEL vs CINACALCET
CILTACABTAGENE AUTOLEUCEL vs CINNARIZINE
CILTACABTAGENE AUTOLEUCEL vs CINRYZE